Loading...
•
Mar 31, 2021
Chemed Q1 2021 Earnings Report
Chemed's financial performance in Q1 2021 was reported, featuring revenue growth and increased EPS, alongside segment-specific results for VITAS and Roto-Rooter.
Key Takeaways
Chemed Corporation reported a 2.2% increase in revenue to $527 million for Q1 2021. GAAP Diluted EPS increased by 18.6% to $4.01, and Adjusted Diluted EPS rose by 20.7% to $4.44. The VITAS segment experienced a revenue decline, while Roto-Rooter saw significant revenue growth.
Chemed's revenue increased by 2.2% to $527 million.
GAAP Diluted EPS increased by 18.6% to $4.01.
Roto-Rooter's revenue increased by 18.9% to $212 million.
VITAS Healthcare's net patient revenue decreased by 6.5% to $316 million.
Revenue by Segment
Forward Guidance
Management anticipates providing updated 2021 earnings guidance in July 2021 as part of the June 30, 2021, earnings press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...